These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9339630)

  • 1. [A study for serodiagnosis of verotoxin-producing Escherichia coli (enterohemorrhagic E. coli) O157 by the bacterial agglutination technique].
    Morooka T; Yamaguchi T; Horikawa K; Matano H; Hirota O; Inoue S; Tanaka M
    Kansenshogaku Zasshi; 1997 Sep; 71(9):924-7. PubMed ID: 9339630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Escherichia coli verotoxin (relationship between verotoxin produced by E. coli O157: H7 and HUS)].
    Matsunaga T; Komoda T
    Nihon Rinsho; 1999 Nov; 57 Suppl():172-5. PubMed ID: 10635805
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serological assay for diagnosis of verotoxin-producing Escherichia coli (VTEC) infection in the patients with diarrhea].
    Kobayashi K; Taguchi M; Seto K; Yoshiya K; Murakami S
    Kansenshogaku Zasshi; 1996 Jan; 70(1):80-6. PubMed ID: 8822056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serodiagnosis by passive hemagglutination test and verotoxin enzyme-linked immunosorbent assay of toxin-producing Escherichia coli infections in patients with hemolytic-uremic syndrome.
    Yamada S; Kai A; Kudoh Y
    J Clin Microbiol; 1994 Apr; 32(4):955-9. PubMed ID: 8027349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indirect hemagglutination assay for antibodies to Escherichia coli lipopolysaccharides O157, O111 and O26 in patients with hemolytic uremic syndrome.
    Morooka T; Matano H; Umeda A; Oda T; Amako K; Karmali MA
    Acta Paediatr Jpn; 1995 Aug; 37(4):469-73. PubMed ID: 7572147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serodiagnosis using microagglutination assay during the food-poisoning outbreak in Japan caused by consumption of raw beef contaminated with enterohemorrhagic Escherichia coli O111 and O157.
    Isobe J; Shima T; Kanatani J; Kimata K; Shimizu M; Kobayashi N; Tanaka T; Iyoda S; Ohnishi M; Sata T; Watahiki M
    J Clin Microbiol; 2014 Apr; 52(4):1112-8. PubMed ID: 24452161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivities and specificities of premier E. coli O157 and premier EHEC enzyme immunoassays for diagnosis of infection with verotxin (Shiga-like toxin)-producing Escherichia coli. The SYNSORB Pk Study investigators.
    Mackenzie AM; Lebel P; Orrbine E; Rowe PC; Hyde L; Chan F; Johnson W; McLaine PN
    J Clin Microbiol; 1998 Jun; 36(6):1608-11. PubMed ID: 9620386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of usefulness of the enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to lipopolysaccharides of Enterohemorrhagic Escherichia coli (EHEC) strains in patients with gastrointestinal disorders and patients with hemolytic uremic syndrome].
    Med Dosw Mikrobiol; 2014; 66(3-4):161-75. PubMed ID: 25804070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum antibodies to verotoxin-producing Escherichia coli (VTEC) strains in patients with haemolytic uraemic syndrome.
    Kishore K; Rattan A; Bagga A; Srivastava RN; Nath NM; Shriniwas
    J Med Microbiol; 1992 Dec; 37(6):364-7. PubMed ID: 1460654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of verocytotoxin from stool and serological testing of patients with diarrhea caused by Escherichia coli O157 : H7.
    Yamada S; Matsushita S; Kai A; Sasaki M; Tsuji A; Kanemitsu T; Yamashita N; Anzai E; Kudoh Y
    Microbiol Immunol; 1993; 37(2):111-8. PubMed ID: 8502176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli.
    Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM
    Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of an Escherichia coli O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea.
    Kim YB; Okuda J; Matsumoto C; Morigaki T; Asai N; Watanabe H; Nishibuchi M
    FEMS Microbiol Lett; 1998 Sep; 166(1):43-8. PubMed ID: 9741083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.
    Friedrich AW; Zhang W; Bielaszewska M; Mellmann A; Köck R; Fruth A; Tschäpe H; Karch H
    Clin Infect Dis; 2007 Jul; 45(1):39-45. PubMed ID: 17554698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. The Société de Néphrologie Pédiatrique.
    Decludt B; Bouvet P; Mariani-Kurkdjian P; Grimont F; Grimont PA; Hubert B; Loirat C
    Epidemiol Infect; 2000 Apr; 124(2):215-20. PubMed ID: 10813145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing activity of bovine colostral antibody against verotoxin derived from enterohemorrhagic Escherichia coli O157:H7 in mice.
    Kuribayashi T; Seita T; Fukuyama M; Furuhata K; Honda M; Matsumoto M; Seguchi H; Yamamoto S
    J Infect Chemother; 2006 Oct; 12(5):251-6. PubMed ID: 17109087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to Escherichia coli O157:H7 in hemolytic uremic syndrome following salmonellosis.
    Flores FX; Jabs K; Thorne GM; Jaeger J; Linshaw MA; Somers MJ
    Pediatr Nephrol; 1997 Aug; 11(4):488-90. PubMed ID: 9260252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex real-time PCR assay for detection of Escherichia coli O157:H7 and screening for non-O157 Shiga toxin-producing E. coli.
    Li B; Liu H; Wang W
    BMC Microbiol; 2017 Nov; 17(1):215. PubMed ID: 29121863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verocytotoxin-producing Escherichia coli infection in household members of children with hemolytic-uremic syndrome in The Netherlands.
    Heuvelink AE; Van de Kar NC; Van Der Velden TJ; Chart H; Monnens LA
    Pediatr Infect Dis J; 1999 Aug; 18(8):709-14. PubMed ID: 10462341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-Time PCR Assay for Detection and Differentiation of Shiga Toxin-Producing Escherichia coli from Clinical Samples.
    Qin X; Klein EJ; Galanakis E; Thomas AA; Stapp JR; Rich S; Buccat AM; Tarr PI
    J Clin Microbiol; 2015 Jul; 53(7):2148-53. PubMed ID: 25926491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.